Technical Data
032264
ATP13A2, CT (ATP13A2, PARK9, Probable cation-transporting ATPase 13A2)
Description:
This gene encodes a member of the P5 subfamily of ATPases which transports inorganic cations as well as other substrates. Mutations in this gene are associated with Kufor-Rakeb syndrome (KRS), also referred to as Parkinson disease 9. Multiple transcript variants encoding different isoforms have been found for this gene.

Applications:
Suitable for use in Western Blot, ELISA

Recommended Dilution:
ELISA: 1:1,000
Western Blot: 1:100-500

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
PabIgGAffinity Purified
SizeStorageShippingSourceHost
200ul-20CBlue IceHumanRabbit
Concentration:
As reported
Immunogen:
ATP13A2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1132-1161 amino acids from the C-terminal region of human ATP13A2.
Purity:
Purified by Protein A affinity chromatography.
Form
Supplied as a liquid in PBS, pH 7.2, 0.09% sodium azide.
Specificity:
Human
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
Dos Santos, A.V., et al. Neurosci. Lett. 485(2):121-124(2010)
Reetz, K., et al. Neurobiol. Dis. 39(3):402-408(2010)
Schneider, S.A., et al. Mov. Disord. 25(8):979-984(2010)
Okada, Y., et al. Hum. Mol. Genet. 19(11):2303-2312(2010)
Fei, Q.Z., et al. Neurosci. Lett. 475(2):61-63(2010)